Market Leader in Europe Aenova is the top player in contract pharmaceutical manufacturing in Europe with a turnover of approximately 750 million Euros. This market leadership presents a prime opportunity for expansion and partnership within the European pharmaceutical industry.

Innovative Technology Integration With a tech stack that includes Microsoft Azure and SAP Ariba, Aenova demonstrates a commitment to cutting-edge technology. Leveraging this innovative technology integration can be a selling point to attract clients looking for advanced and efficient manufacturing solutions.

Global CDMO Presence Aenova's status as a leading Contract Development and Manufacturing Organization (CDMO) worldwide positions them as an attractive partner for pharmaceutical companies seeking global reach. Utilizing Aenova's multinational presence can unlock sales opportunities in various international markets.

Diverse Capabilities in Dosage Forms Aenova's expertise covers the entire range of pharmaceutical and dietary supplement dosage forms for human and animal health products. This diverse capability equips the company to cater to a wide spectrum of client needs, presenting ample opportunities for tailored solutions and product expansions.

Strategic Acquisitions and Investments Aenova's significant investments in development and manufacturing capacities have fueled new technologies and innovations. Highlighting these strategic acquisitions can attract potential clients looking for partners who continually enhance their capabilities and stay ahead of industry trends.